cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lexicon Pharmaceuticals Inc
34 own
27 watching
Current Price
$2.27
$0.03
(1.34%)
logo-lxrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
428.41M
52-Week High
52-Week High
3.48
52-Week Low
52-Week Low
1.31
Average Volume
Average Volume
0.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
8.9838
iconMarket Capitalization428.41M
icon52-Week High3.48
icon52-Week Low1.31
iconAverage Volume0.4M
iconDividend Yield--
iconP/E Ratio8.9838
What does the Lexicon Pharmaceuticals Inc do?
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of human diseases. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with SSA therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that is in Phase 3 clinical trials for use in the treatment of type 1 and type 2 diabetes; LX2761, which is in Phase 1 development for use in the treatment of diabetes; and LX9211 for use as a treatment for neuropathic pain. The company has license and collaboration agreements with Sanofi; Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.
Read More
How much money does Lexicon Pharmaceuticals Inc make?
News & Events about Lexicon Pharmaceuticals Inc.
Ticker Report
1month ago
StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) from a sell rating to a hold rating in a research note released on Thursday. Lexicon Pharmaceuticals Stock Performance Shares of NASDAQ:LXRX opened at $2.08 on Thursday. The company has a market capitalization ...
Globe Newswire
2 months ago
THE WOODLANDS, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the following investor conferences taking place November 29 - December 1, 2022: 34th Annual Piper Sandler Healthcare Conference5th Annual Evercore ISI HealthCONx ...
Globe Newswire
2 months ago
THE WOODLANDS, Texas, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the 13th Annual Jefferies London Healthcare Conference, taking place November 15-17, 2022. Jeff Wade, Lexiconspresident and chief financial officer, will make a ...
Globe Newswire
2 months ago
Conference Call and Webcast at 5:00pm ET on November 14, 2022,Following the Oral PresentationTHE WOODLANDS, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the final results from the Phase 2 RELIEF-DPN-1 trial of its investigational drug ...
Globe Newswire
2 months ago
Post hoc analysis of clinical data from the SCORED trial presented at the American Society of Nephrology Kidney Week 2022 annual scientific meeting, including evidence that: Sotagliflozin significantly reduced urine albumin-to-creatinine ratio (UACR)Sotagliflozin had favorable effects on albuminuria...
Frequently Asked Questions
Frequently Asked Questions
What is Lexicon Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Lexicon Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Lexicon Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Lexicon Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Lexicon Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Lexicon Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Lexicon Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Lexicon Pharmaceuticals Inc?
plus_minus_icon
What percentage is Lexicon Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Lexicon Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.27
$0.03
(1.34%)
logo-lxrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00